KIRSCH, B.; DUBOIS, J.; CHADHA, D. A Multi-Center, Open-Label Study to Assess Pharmacokinetics (PK), Safety and Tolerability of Sofpironium Bromide Gel, 15% Applied Topically to Children and Adolescents, ≥9 to <17 Years of Age, with Axillary Hyperhidrosis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, p. S54, 2019. DOI: 10.25251/skin.3.supp.54. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/782. Acesso em: 23 jul. 2024.